Literature DB >> 22689319

A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation.

Sophie Cohen, Carline E Tacke, Bart Straver, Natasja Meijer, Irene M Kuipers, Taco W Kuijpers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22689319     DOI： 10.1136/annrheumdis-2012-201658

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  45 in total

Review 1.  2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.

Authors:  Frank Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2021-02-06       Impact factor: 3.725

2.  IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β.

Authors:  Youngho Lee; Daiko Wakita; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Ganghua Huang; Thomas J A Lehman; Michael C Fishbein; Hal M Hoffman; Timothy R Crother; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

3.  Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.

Authors:  Judith Sánchez-Manubens; Jordi Antón; Rosa Bou; Estíbaliz Iglesias; Joan Calzada-Hernandez; Sergi Borlan; Clara Gimenez-Roca; Josefa Rivera
Journal:  Rheumatol Int       Date:  2016-05-23       Impact factor: 2.631

Review 4.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

Review 5.  Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Authors:  Jane C Burns; Isabelle Koné-Paut; Taco Kuijpers; Chisato Shimizu; Adriana Tremoulet; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 6.  A child with X-linked agammaglobulinemia and Kawasaki disease: an unusual association.

Authors:  Dhrubajyoti Sharma; Sandesh Guleria; Deepti Suri; Amit Rawat; Ravinder Garg; Surjit Singh
Journal:  Rheumatol Int       Date:  2017-04-01       Impact factor: 2.631

7.  Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).

Authors:  Adriana H Tremoulet; Sonia Jain; Susan Kim; Jane Newburger; Moshe Arditi; Alessandra Franco; Brookie Best; Jane C Burns
Journal:  Contemp Clin Trials       Date:  2016-04-11       Impact factor: 2.226

8.  Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.

Authors:  Pui Y Lee; Megan Day-Lewis; Lauren A Henderson; Kevin G Friedman; Jeffrey Lo; Jordan E Roberts; Mindy S Lo; Craig D Platt; Janet Chou; Kacie J Hoyt; Annette L Baker; Tina M Banzon; Margaret H Chang; Ezra Cohen; Sarah D de Ferranti; Audrey Dionne; Saddiq Habiballah; Olha Halyabar; Jonathan S Hausmann; Melissa M Hazen; Erin Janssen; Esra Meidan; Ryan W Nelson; Alan A Nguyen; Robert P Sundel; Fatma Dedeoglu; Peter A Nigrovic; Jane W Newburger; Mary Beth F Son
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

9.  Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.

Authors:  Christine W Bruggeman; Sietse Q Nagelkerke; Wendy Lau; Cedric Manlhiot; Masja de Haas; Robin van Bruggen; Brian W McCrindle; Rae S M Yeung; Taco W Kuijpers
Journal:  Blood Adv       Date:  2020-07-28

10.  Interleukin-1 Beta-Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment.

Authors:  Rebecca A Porritt; Janet L Markman; Daisuke Maruyama; Begum Kocaturk; Shuang Chen; Thomas J A Lehman; Youngho Lee; Michael C Fishbein; Magali Noval Rivas; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-30       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.